These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4971298)

  • 1. [Inhibitory effects of an antidiabetic biguanide, NN'-dimethylbiguanide, on the lipid disturbances induced by the administration of cholesterol in rabbits].
    Marquié G; Agid R
    C R Acad Hebd Seances Acad Sci D; 1968 Jun; 266(26):2465-8. PubMed ID: 4971298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of antidiabetic biguanides on various types of lipid mobilization in the rabbit].
    Marquié G; Agid R
    J Physiol (Paris); 1973 Sep; 66(3):345-56. PubMed ID: 4788518
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive effects of NN-dimethylbiguanide on hepatic steatosis of nutritional origin in rabbits].
    Marquié G; Agid R
    J Physiol (Paris); 1971; 63(2):75A. PubMed ID: 5561564
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention, by antidiabetic biguanides, of hepatic cholesteatosis induced by cholesterol in the rabbit. Histopathological examination].
    Marquié G; Agid R; Amiel S; Guilhem A
    C R Seances Soc Biol Fil; 1970; 164(3):648-54. PubMed ID: 4250425
    [No Abstract]   [Full Text] [Related]  

  • 5. [NN-dimethylbiguanide attenuates the lipid disorders of rats on an atherogenic diet].
    Estève B; Marquié G; Agid R
    C R Acad Hebd Seances Acad Sci D; 1975 Jun; 280(21):2465-8. PubMed ID: 808284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antidiabetic biguanides in the prevention of fatty liver induced by high-fat diet in rabbits. Histopathologic examination].
    Agid R; Amiel S; Guilhem A; Marquié G
    Pathol Biol (Paris); 1971; 19(15):727-33. PubMed ID: 4942504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive effects of NN'-dimethylbiguanide on the development of cholesterol-induced arteriosclerosis in rabbits].
    Agid R; Marquié G
    C R Acad Hebd Seances Acad Sci D; 1969 Sep; 269(11):1000-3. PubMed ID: 4981421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification by certain hypoglycemic sulfonamides of lipid disturbances induced by cholesterol administration in rabbits].
    Marquié G; Agid R
    C R Seances Soc Biol Fil; 1968; 162(2):563-8. PubMed ID: 4237632
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of bile salt absorption by blood-sugar lowering biguanides.
    Caspary WF; Creutzfeldt W
    Diabetologia; 1975 Apr; 11(2):113-7. PubMed ID: 1149945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effects of metformin (NN-dimethylbiguanide) on hypothyroidism and fatty infiltration of the adrenal cortex induced by a cholesterol diet in rabbits].
    Marquié G; Agid R
    Pathol Biol (Paris); 1973 Feb; 21(2):133-9. PubMed ID: 4573141
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of carnitine in promoting the effect of antidiabetic biguanides on hepatic ketogenesis.
    Sandor A; Kerner J; Alkonyi I
    Biochem Pharmacol; 1979 Apr; 28(7):969-74. PubMed ID: 444288
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the mechanism of action of phenethylbiguanide (PEBG). II. Effect on spontaneous and glucagon-induced hepatic glycogenolysis in vitro].
    Fratino P; Rodari T; Maggi G
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1881-3. PubMed ID: 5628805
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the effect of a principle extracted from Eugenia Jambolana bark with NN-methyldimethyl biguanide and glybutamide on induced hypoglycemia in normal rats].
    Ratsimamanga AR; Lefournier-Contensou C; Bibal-Prot P
    C R Acad Hebd Seances Acad Sci D; 1972 Aug; 275(8):913-5. PubMed ID: 4628567
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of oral hypoglycemic agents on the fatty acid composition of liver and depot lipids in rats].
    Bernhard K; Spreng E
    Z Klin Chem Klin Biochem; 1971 May; 9(3):242-4. PubMed ID: 5153836
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current views on the mode of action of blood glucose lowering biguanides].
    Segre G
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():627-35. PubMed ID: 4984396
    [No Abstract]   [Full Text] [Related]  

  • 16. Biguanides drugs: Past success stories and promising future for drug discovery.
    Grytsai O; Myrgorodska I; Rocchi S; Ronco C; Benhida R
    Eur J Med Chem; 2021 Nov; 224():113726. PubMed ID: 34364161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
    [No Abstract]   [Full Text] [Related]  

  • 18. New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
    Abbas SY; Basyouni WM; El-Bayouk KAM; Tohamy WM; Aly HF; Arafa A; Soliman MS
    Drug Res (Stuttg); 2017 Oct; 67(10):557-563. PubMed ID: 28651259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
    Srivastava PP; Murthy PS; Mukherjee SK
    Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.
    Sweeney D; Raymer ML; Lockwood TD
    Biochem Pharmacol; 2003 Aug; 66(4):663-77. PubMed ID: 12906931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.